glp-1 lab monitoring the Inside: Why Weight Loss Needs Oversight 📉🧪 With the massive rise of weight loss medications in the USA, everyone is talking about the "before and after" photos. But semaglutide lab monitoring How Do

Retatrutide vs Survodutide: Triple vs Dual Agonist Comparison for Obesity and MASH Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data

While new prescriptions of these medications for DMT2 increased 128%, it may be of more interest that new prescriptions for obesity grew 352% during this time

Without insurance, brand-name Contrave can run $250$400+ per month

Understanding contraindicationsconditions that make a treatment inadvisable or unsafeis essential before beginning therapy

Mercks absence from the GLP-1 weight-loss scene is conspicuous given its size

This hypothesis has been confirmed in clinical trials including hypertensive patients that demonstrated an improved blood pressure control (30, 31) and reduction of cardiovascular events (31) when anti-hypertensive drugs have been administered at bedtime